Ameriprise Financial Inc Clovis Oncology, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $885 - $4,158	-1,405 Reduced 8.4%	15,330 $28,000
Q1 2022 May 16, 2022	BUY	$1.43 - $3.14 $2,009 - $4,411	1,405 Added 9.17%	16,735 $34,000
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $5,764 - $10,162	-2,135 Reduced 12.22%	15,330 $42,000
Q3 2021 Nov 15, 2021	SELL	$4.06 - $5.8 $5,805 - $8,294	-1,430 Reduced 7.57%	17,465 $78,000
Q2 2021 Aug 16, 2021	BUY	$5.02 - $7.05 $11,144 - $15,651	2,220 Added 13.31%	18,895 $109,000
Q1 2021 May 17, 2021	BUY	$4.81 - $10.34 $80,206 - $172,419	16,675 New	16,675 $117,000
Q4 2020 Feb 12, 2021	SELL	$4.13 - $6.41 $66,996 - $103,983	-16,222 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.82 - $7.72 $1,735 - $2,779	360 Added 2.27%	16,222 $94,000
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $34,310 - $58,430	-6,030 Reduced 27.54%	15,862 $107,000
Q1 2020 May 15, 2020	BUY	$3.77 - $11.0 $82,532 - $240,812	21,892 New	21,892 $139,000
Q3 2019 Nov 14, 2019	SELL	$3.93 - $15.35 $189,870 - $741,604	-48,313 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $2.7 Million - $5.42 Million	-211,076 Reduced 81.37%	48,313 $721,000
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $3.7 Million - $6.34 Million	209,429 Added 419.19%	259,389 $6.44 Million
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $480,470 - $1.35 Million	-41,313 Reduced 45.26%	49,960 $896,000
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $11.8 Million - $19.9 Million	-403,171 Reduced 81.54%	91,273 $2.68 Million
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $15.1 Million - $22.4 Million	-358,507 Reduced 42.03%	494,444 $22.5 Million
Q1 2018 May 15, 2018	BUY	$50.12 - $67.72 $18.9 Million - $25.5 Million	377,073 Added 79.24%	852,951 $45 Million
Q4 2017 Feb 12, 2018	SELL	$57.69 - $84.58 $323,987 - $475,001	-5,616 Reduced 1.17%	475,878 $32.4 Million
Q3 2017 Nov 07, 2017	BUY	$67.17 - $84.81 $32.3 Million - $40.8 Million	481,494	481,494 $39.7 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account